SCHEMBL69370

SCHEMBL69370

Oc1cc(O)cc(I)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1687060 0.92
SCHEMBL7630079 0.78
SCHEMBL1710893 0.78
SCHEMBL1029025 0.78
SCHEMBL10165086 0.78
SCHEMBL2514629 0.78
SCHEMBL11566823 0.78
Phloroglucinol SCHEMBL26311 0.78
Phloroglucinol SCHEMBL2889628 0.78 BACE1 (1.00)
Phloroglucinol SCHEMBL30542958 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115684141-A Test strip for shortening detection time of saliva glucose and preparation method and application thereof 中科康磁医疗科技(苏州)有限公司 2023-02-03 CN claimed
CN-105037100-A Synthetic method of oxyresveratrol UNIV CHANGSHA SCIENCE 2015-11-11 CN claimed
US-7524373-B2 Apparatus and semiconductor co-crystal UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2009-04-28 US claimed
WO-2007089785-A2 APPARATUS AND SEMICONDUCTOR CO-CRYSTAL UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2007-08-09 WO claimed
US-20070178621-A1 Apparatus and semiconductor co-crystal UNIVERISTY OF IOWA RESEARCH FOUNDATION 2007-08-02 US claimed
CN-113461555-B Preparation method of terbutaline 天津药业研究院股份有限公司 2025-06-17 CN disclosed
WO-2024050825-A1 COMPOUNDS AS MLKL INHIBITORS NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2024-03-14 WO disclosed
WO-2024050825-A1 COMPOUNDS AS MLKL INHIBITORS NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2024-03-14 WO disclosed
WO-2023192901-A9 QUINOLINE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS ESCIENT PHARMACEUTICALS, INC. (US) 2023-12-14 WO disclosed
US-11800793-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-24 US disclosed
US-11800793-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-24 US disclosed
US-11800793-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-24 US disclosed
EP-0375404-B1 Heterocyclic derivatives ICI PLC (GB) 1994-02-09 EP disclosed
US-5236919-A Inhibitorsof enzyme 5-lipoxygenase IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-08-17 US disclosed
US-5234950-A Antiallergens, antiinflammatory agents; cardiovascular disorders, antiarthritic IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-08-10 US disclosed
US-5134148-A Heterocycles for use as inhibitors of leukotrienes IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-07-28 US disclosed
US-5098930-A Inhibitors of lipoxygenase for treatment of diseases mediated with leukotrienes IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-03-24 US disclosed
CN-1046903-A Process for preparing heterocyclic ether derivatives ICI PLC (GB) 1990-11-14 CN disclosed
EP-0385662-A2 Heterocycles with inhibitory activity of 5-lipoxygenase ZENECA LIMITED (GB) 1990-09-05 EP disclosed
EP-0375404-A2 Heterocyclic derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-06-27 EP disclosed